Clinical, Radiological, and Etiological Aspects of Pachymeningitis: A Study of 24 Cases
- PMID: 38984004
- PMCID: PMC11231805
- DOI: 10.7759/cureus.61988
Clinical, Radiological, and Etiological Aspects of Pachymeningitis: A Study of 24 Cases
Abstract
Introduction and importance Hypertrophic pachymeningitis (HP) is an uncommon disorder with varied etiological origins and heterogeneous clinical presentation. Establishing the etiological diagnosis poses a challenge, but prompt identification provides a treatment window, potentially leading to a reversal of symptoms. MRI is the reference examination, allowing not only the early diagnosis of pachymeningitis but also the assessment of its extent and importance, detection of possible complications, and suggestion of etiology. Case presentation We conducted a retrospective study involving 24 patients recruited over 5 years for who brain imaging had revealed the presence of pachymeningitis. The average age of the patients was 40 years, with a male-to-female ratio of 0.6. Clinical discussion Headache was present in 54.17% of patients. All the patients underwent MRI examinations utilizing different sequences, with subsequent Gadolinium injection showing localized and asymmetrical meningeal thickening in 13 cases, and diffuse in the rest. The cerebrospinal fluid study unveiled an inflammatory fluid characterized by a lymphocytic predominance and hyperproteinorrhea, noted in 50% of the patients. The histopathological analysis of a stereotactic biopsy conducted on an individual patient revealed non-diagnostic results. The etiological investigation was dominated by tuberculosis, which was detected in 33.3% of cases. Idiopathic origin was identified in 16.7% of patients. Conclusion Meningeal thickening is rare, and the multitude of potential causes makes the etiological investigation challenging unless they fall within the scope of secondary meningeal disorders; otherwise, a dural biopsy becomes necessary, and the prompt initiation of treatment, along with determining the etiology influences the prognosis.
Keywords: cerebral tuberculosis; hypertrophic pachymeningitis; infiltration of the dura mater; mri; sarcoidosis.
Copyright © 2024, Samah et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Comité d'ethique d'oujda issued approval not applicable. Ethical clearance is not required for this retrospective study, according to our institution's research ethics committee. The committee has verified that the study adheres to standard clinical practices and does not involve experimental interventions or the need for additional data collection. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
A clinical approach to hypertrophic pachymeningitis.Arq Neuropsiquiatr. 2020 Dec;78(12):797-804. doi: 10.1590/0004-282X20200073. Arq Neuropsiquiatr. 2020. PMID: 33295420
-
A Rare Diagnosis of Aseptic Hypertrophic Pachymeningitis: A Case of Mycobacterial Tuberculosis Origin.Cureus. 2023 Sep 26;15(9):e45973. doi: 10.7759/cureus.45973. eCollection 2023 Sep. Cureus. 2023. PMID: 37900382 Free PMC article.
-
Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.Autoimmun Rev. 2023 Apr;22(4):103285. doi: 10.1016/j.autrev.2023.103285. Epub 2023 Feb 2. Autoimmun Rev. 2023. PMID: 36738953 Review.
-
Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.Biomed Res Int. 2020 Aug 14;2020:2926419. doi: 10.1155/2020/2926419. eCollection 2020. Biomed Res Int. 2020. PMID: 32879880 Free PMC article.
-
Idiopathic hypertrophic pachymeningitis.Neurology. 2004 Mar 9;62(5):686-94. doi: 10.1212/01.wnl.0000113748.53023.b7. Neurology. 2004. PMID: 15007115 Review.
References
-
- Inflammatory hypertrophic cranial pachymeningitis [Article in French] Masson C, Boukriche Y, Colombani JM. https://pubmed.ncbi.nlm.nih.gov/11285778/ Presse Med. 2001;30:411–416. - PubMed
-
- Hypertrophic pachymeningitis: varied manifestations of a single disease entity. Prabhakar S, Bhatia R, Lal V, Singh P. https://tspace.library.utoronto.ca/retrieve/2490/ni02012.pdf. Neurol India. 2002;50:45–52. - PubMed
-
- Idiopathic hypertrophic cranial pachymeningitis. Sylaja PN, Cherian PJ, Das CK, Radhakrishnan VV, Radhakrishnan K. https://pubmed.ncbi.nlm.nih.gov/11960152/ Neurol India. 2002;50:53–59. - PubMed
-
- Pachymeningitis [Article in French] Fain O, Mekinian A. http://dx.doi.org/10.1016/j.revmed.2017.03.011. Rev Med Interne. 2017;38:585–591. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous